What are the National Comprehensive Cancer Network (NCCN) guidelines for neurological testing in the evaluation of acute myeloid leukemia (AML)?

Updated: May 26, 2020
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The NCCN further recommends the following tests if neurologic symptoms are present [25] :

  • CT of brain without contrast, if CNS hemorrhage suspected
  • Brain magnetic resonance imaging (MRI) with contrast, if leukemic meningitis suspected
  • Positron emission tomography (PET)/CT, if clinical suspicion for extramedullary disease
  • Lumbar puncture

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!